Alcon AG (ALC) is next scheduled to report earnings on Aug 10, 2026 (after market close). The consensus analyst EPS estimate for the upcoming quarter is $0.77.
Heading into this report, the model's fair value estimate sits 8.7% above the current price (model fair value differential above current price). Descriptive context only — not a forecast of the earnings result.
Equity Rank computed model fair value for ALC from 10 independent valuation methods with sufficient data. 5 place fair value above the current price of $67.05, and 5 place it below. The model-blended estimate lands at $72.91 — a model fair value differential of 8.7% above the current price under these model assumptions. The methods are evenly split, reflecting genuine dispersion in the estimate.
Equity Rank's fundamental strength composite scores ALC at 66.5/100 (B, Solid), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, free cash flow has compounded at +50.5% per year and gross margin has moved +0.8 pp. Its SAVE composite score has moved +0.1 over the past 30 days.
Alcon AG (ALC) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.
Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.
All Healthcare stocks with model fair values · Undervalued Healthcare stocks
Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator
Data study: 19 valuation models across 3,091 US stocks · Compare any two stocks